Mackenzie Financial
HRMY icon

Mackenzie Financial’s Harmony Biosciences HRMY Stock Holding History

Mackenzie Financial’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.9M Buy
107,216
+34,304
+47% +$1.08M ﹤0.01% 885
2026
Q1 		$2.04M Buy
72,912
+32,216
+79% +$1.06M ﹤0.01% 923
2025
Q4 		$1.53M Buy
+40,696
New +$1.34M ﹤0.01% 946
2023
Q1 		– Sell
-4,044
Closed -$223K – 1559
2022
Q4 		$223K Sell
4,044
-1,041
-20% -$57.2K ﹤0.01% 1205
2022
Q3 		$225K Buy
+5,085
New +$248K ﹤0.01% 1202

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mackenzie Financial's HRMY Position: Q2 2026 in Review

Mackenzie Financial increased its Harmony Biosciences (HRMY) stake by 47% in Q2 2026, buying an estimated $1.08M and bringing the position to 107,216 shares worth $3.9M. The position accounts for ﹤0.01% of the portfolio, ranked #885.

Mackenzie Financial first reported a position in HRMY in Q3 2022 and has held it in 5 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Mackenzie Financial held 107,216 shares of Harmony Biosciences worth $3.9M as of Q2 2026.
  • Mackenzie Financial bought 34,304 Harmony Biosciences shares in Q2 2026, an estimated $1.08M.
  • Harmony Biosciences made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #885 holding.
  • Mackenzie Financial first reported a position in Harmony Biosciences in Q3 2022 and has held it in 5 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.